Advertisement

Topics

Proteon Therapeutics, Inc. Company Profile

16:48 EST 19th November 2017 | BioPortfolio

Proteon Therapeutics, Inc., is a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases. The company is headquartered in Waltham, Mass., and has research facilities in Kansas City, Mo. For additional information, please visit www.proteontherapeutics.com.


News Articles [537 Associated News Articles listed on BioPortfolio]

Proteon Therapeutics: Could Presentations In November Push Shares Even Higher?

Proteon Therapeutics: Hope For Kidney Failure Patients And Special-Situations Investors

Proteon Therapeutics (PRTO) Presents At Stifel 2017 Healthcare Conference - Slideshow

Proteon grosses $22mm through private preferred share sale

Proteon Therapeutics Inc. (treatments for kidney and vascular diseases) grossed $22mm through the private sale of 22k Series A preferred shares at $1k. The stock is convertible into 22.1mm common at $...

Zeulab Proteon allergen test strips and kits

The checking of raw materials and the identification of critical points during food processing are of vital importance to avoid hidden allergens and cross-contaminations.Testing the final product is n...

ROTY Edition 1 Volume 7: Proteon - This Failed 2014 IPO Could Be A Big Winner

Proteon Therapeutics Inc PRTO Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

SummaryProteon Therapeutics Inc Proteon is a latestage biopharmaceutical company that develops pharmaceutical products for the treatment of renal and vascular diseases. The company develops investigat...

Proteon Announces $22 Million Private Placement

  Life Sciences Jobs   ...

Clinical Trials [120 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1168 Associated Companies listed on BioPortfolio]

Proteon Therapeutics Inc.

Proteon Therapeutics Inc. is a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kid...

Proteon Therapeutics, Inc.

Proteon Therapeutics, Inc., is a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular di...

Proteon Therapeutics

Proteon Therapeutics, Inc. is a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with ki...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Proteon Therapeutics, Inc." on BioPortfolio

We have published hundreds of Proteon Therapeutics, Inc. news stories on BioPortfolio along with dozens of Proteon Therapeutics, Inc. Clinical Trials and PubMed Articles about Proteon Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Proteon Therapeutics, Inc. Companies in our database. You can also find out about relevant Proteon Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Endocrinology
Diabetes Diabetes Endocrine Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several groups of h...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record